TALC

LOE Approaching

talc

NDAINTRAPLEURALPOWDERPriority Review
Approved
Dec 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT07291700N/ARecruiting

Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy

Started Nov 2025
167 enrolled
Gastroesophageal Reflux
NCT02517749N/ACompleted

Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management

Started Aug 2015
142 enrolled
Pleural Effusion, Malignant
NCT01928888Phase 4Completed

Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes

Started May 2003
559 enrolled
Heartburn
NCT00111774Phase 2Completed

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

Started Mar 2002
150 enrolled
Colorectal CancerCarcinoma
NCT00002622Phase 3Completed

Talc in Treating Patients With Malignant Pleural Effusion

Started Dec 1994
501 enrolled
Metastatic Cancer
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.